Mirum Pharmaceuticals Inc [MIRM] stock prices are up 4.28% to $81.07 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The MIRM shares have gain 26.47% over the last week, with a monthly amount glided 17.22%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Mirum Pharmaceuticals Inc [NASDAQ: MIRM] stock has seen the most recent analyst activity on September 24, 2025, when TD Cowen initiated its Buy rating and assigned the stock a price target of $95. Stifel started tracking the stock assigning a Buy rating and suggested a price target of $48 on April 17, 2024. H.C. Wainwright reiterated its recommendation of a Buy and reduced its price target to $58 on December 18, 2023. In a note dated November 13, 2023, Morgan Stanley initiated an Overweight rating and provided a target price of $60 on this stock.
The stock price of Mirum Pharmaceuticals Inc [MIRM] has been fluctuating between $36.88 and $79.95 over the past year. Currently, Wall Street analysts expect the stock to reach $102.2 within the next 12 months. Mirum Pharmaceuticals Inc [NASDAQ: MIRM] shares were valued at $81.07 at the most recent close of the market. An investor can expect a potential return of 26.06% based on the average MIRM price forecast.
Analyzing the MIRM fundamentals
The Mirum Pharmaceuticals Inc [NASDAQ:MIRM] reported sales of 471.79M for trailing twelve months, representing a surge of 47.17%. Gross Profit Margin for this corporation currently stands at 0.8% with Operating Profit Margin at -0.09%, Pretax Profit Margin comes in at -0.09%, and Net Profit Margin reading is -0.09%. To continue investigating profitability, this company’s Return on Assets is posted at -0.05, Equity is -0.16 and Total Capital is -0.07. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 76.90 points at the first support level, and at 72.73 for the second support level. However, for the 1st resistance point, the stock is sitting at 83.47, and for the 2nd resistance point, it is at 85.87.
Ratios To Look Out For
It’s worth pointing out that Mirum Pharmaceuticals Inc [NASDAQ:MIRM]’s Current Ratio is 3.31. As well, the Quick Ratio is 3.16, while the Cash Ratio is 1.76. Considering the valuation of this stock, the price to sales ratio is 8.88, the price to book ratio is 14.24.
Transactions by insiders
Recent insider trading involved SAIRA RAMASASTRY, Director, that happened on Dec 22 ’25 when 5000.0 shares were purchased. Director, Ramasastry Saira completed a deal on Dec 18 ’25 to sell 2000.0 shares. Meanwhile, Director MICHAEL GREY bought 50000.0 shares on Dec 19 ’25.
